MENA-ISN – Page 4 – Middle East, Eurasia And Africa Influenza Stakeholders Network (ME'NA-ISN)

Call to Action – PROTECTING THE VULNERABLE AGAINST INFLUENZA

Seasonal Influenza Vaccination among Patients with Comorbidities in the Countries of the GCC: A Responsibility or an Option?

Determinants of parental seasonal influenza vaccine hesitancy in the Eastern Mediterranean region: A cross-sectional study

The Role of Psychological Factors and Vaccine Conspiracy Beliefs in Influenza Vaccine Hesitancy and Uptake among Jordanian Healthcare Workers during the COVID-19 Pandemic

Influenza: Newer Challenges // Webinar

Middle East, Eurasia & Africa Influenza Stake Holders Network (ME’NA-ISN) & Indian Chest Society (ICS) 3rd January 2022

Semi-annual Bulletin – Volume 4; Issue Number 1; 2024

Half year summary (January – June) 2024
Volume 4; Issue Number 1; 2024

Semi-annual Bulletin – Volume 3; Issue Number 1; 2023

Semi-annual Bulletin – Volume 3; Issue Number 1; 2023
Volume 3; Issue Number 1; 2023

Semi-annual Bulletin – Volume2; Issue Number 2; 2022

Half year summary (August-December) 2022
Volume 2; Issue Number 2; 2022

Semi-annual Bulletin – Volume2; Issue Number 1; 2022

Half year summary (January-July) 2022
Volume 2; Issue Number 1; 2022

EFIM / ME’NA-ISN Conjoint Webinar Influenza and Multimorbidity

May 17, 2022

Slide

Train-the-Trainer Workshop

Workshop on Live Attenuated Influenza Vaccine in Dubai, UAE (May 3, 2025)

Supported by an unrestricted educational grant by AstraZeneca.

Half year summary (January – June) 2024Volume 4; Issue Number 1; 2024

Half year summary (January – June) 2024
Volume 4; Issue Number 1; 2024

Click to see new bulletin

Slide

ME’NA-ISN Research Award

The Middle East, Eurasia And Africa Influenza Stakeholders Network (ME’NA-ISN) wishes to honour research by awarding one researcher with the ME’NA-ISN Research Award. Aimed at motivating young and active researchers towards meaningful research in the MENA region, the award will support research in the field of influenza or influenza vaccination. In 2024, the award shall be conferred to an individual who submits a research proposal to be developed within the maximum of 2 years from the time of receiving the funds (estimated to be in (December 2026).

Apply now

Slide

Click here to register

Click here to submit your abstract

Semi-annual Bulletin – Volume 3; Issue Number 1; 2023

Semi-annual Bulletin – Volume 3; Issue Number 1; 2023
Volume 3; Issue Number 1; 2023

VACCiMENA-Health Care Providers

Please click for VACCiMENA-HCP Questionnaire

New article of MENA-ISN Working Group

Slide